Search For "pharmaceutical"
Moderna says US ordered 100 mln additional doses of coronavirus vaccine
Updated : 5 years, 3 months ago IST
Washington [US], December 12 (ANI/Sputnik): The United States has secured 100 million more doses of the mRNA coronavirus vaccine by US pharmaceutical company Moderna, the developer said in a press release.
Read More
Subhasis Das appointed Managing Director, Alfa Laval India Private Limited
Updated : 5 years, 3 months ago IST
Pune (Maharashtra) [India], December 10 (ANI/PRNewswire): Subhasis Das has been appointed as Managing Director, Alfa Laval India Private Limited with effect from December 1, 2020.
Read More
Pfizer becomes first pharma company in India to seek emergency use nod for
Updated : 5 years, 3 months ago IST
New Delhi [India], December 6 (ANI): Pfizer India has become the first pharmaceutical firm to approach the Drugs Controller General of India (DCGI) seeking an emergency use authorisation for its Covid-19 vaccine in the country.
Read More
CFBP holds its 32nd Jamnalal Bajaj Awards for Fair Business Practices
Updated : 5 years, 3 months ago IST
Mumbai (Maharashtra) [India], December 2 (ANI/NewsVoir): Amidst the current scenario where businesses are trying to get back in motion, CFBP held the 32nd Jamnalal Bajaj Awards for Fair Business Practices at the Indian merchant chambers lifting spirits of the corporates on the evening of 1 D
Read More
Glenmark to divest select Anti-Allergy brands to Dr Reddy's in Russia, Ukr
Updated : 5 years, 3 months ago IST
Mumbai (Maharashtra) [India], November 29 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd. today announced that it has entered into a definitive agreement with Dr. Reddy's Laboratories Ltd. to divest - subject to completion of certain precedent actions and closing activities - its brand Mo
Read More
UK regulator receives govt's request to assess Oxford/AstraZeneca COVID-19
Updated : 5 years, 4 months ago IST
London [UK], November 27 (ANI/Sputnik): The UK Medicines and Healthcare products Regulatory Agency (MHRA) confirmed on Friday that it has received a request from the government's Department of Health and Social Care to assess the COVID-19 vaccine being developed by the University of Oxford a
Read More
COVID-19: Russia agrees to produce Sputnik V vaccine in India
Updated : 5 years, 4 months ago IST
Moscow [Russia], November 27 (ANI): The Russian Sovereign Wealth Fund and India's pharmaceutical company Hetero have agreed to produce over 100 million doses per year of the Russian COVID-19 vaccine Sputnik V in India, according to a statement on Sputnik V Twitter account on Friday.
Read More
Russian research center suggests use of Sputnik V to boost efficacy of Ast
Updated : 5 years, 4 months ago IST
Moscow [Russia], November 27 (ANI/Sputnik): The Russian Gamaleya research institute has suggested UK pharmaceutical company AstraZeneca try to boost the efficacy of its COVID-19 vaccine, combining it with a shot of Russian COVID-19 vaccine Sputnik V.
Read More
Glenmark Pharmaceuticals secures its position in the prestigious Dow Jones
Updated : 5 years, 4 months ago IST
Mumbai (Maharashtra) [India], November 26 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led global integrated pharmaceutical company, today announced that the company has been listed in the Dow Jones Sustainability Index (DJSI), under the category of emerging markets
Read More
New study to enhance chronic pain treatments
Updated : 5 years, 4 months ago IST
Fukuoka [Japan], November 26 (ANI): Researchers at Kyushu University's Graduate School of Pharmaceutical Sciences have discovered a unique population of spinal cord astrocytes with a role in producing pain hypersensitivity to strengthen the effect of chronic pain treatments.
Read More
India and Bahrain set for health trade boom amid growing demand
Updated : 5 years, 4 months ago IST
Manama [Bahrain], November 23 (ANI/NewsVoir): India and Bahrain are set for a boom in health trade amid a GCC-wide increase in demand for pharmaceuticals and medical devices.
Read More
Recently published data on Favipiravir as treatment for mild to moderate C
Updated : 5 years, 4 months ago IST
Mumbai (Maharashtra) [India], November 23 (ANI/PRNewswire): The oral antiviral medication Favipiravir, that prevents the replication phase of the virus life-cycle, leads to significant improvement in clinical cure in patients with mild to moderate COVID-19.
Read More